Colgate-Palmolive Raises Outlook as Q2 Sales Hit $5.36 Billion, Beating Estimates

Key Facts

1Colgate-Palmolive net sales increased by 4.9% to $5.36 billion in the second quarter.

2The company raised its full-year earnings outlook, anticipating mid-single-digit growth.

Reflecting the resilience of the consumer staples sector amid economic uncertainty, Colgate-Palmolive reported robust second-quarter 2026 results. Net sales increased by 4.9% to reach $5.36 billion, exceeding analyst expectations driven by organic sales growth and pricing gains. Consequently, the company raised its full-year earnings outlook, now anticipating mid-single-digit growth in its base business earnings per share.

The growth was primarily fueled by strong regional performance in Latin America, Europe, and Asia-Pacific, which offset a decline in North American sales caused by softer consumer demand. Per market data, the company maintained strong profitability as gross profit margins expanded to 61.5%, supported by productivity initiatives and innovation across its oral care and Hill’s Pet Nutrition segments.

Colgate-Palmolive (CL) shares stood at $91.3 at the close of July 31, 2026, having traded between a day low of $89.6 and a high of $91.68. Traders are closely monitoring global consumer demand trends, especially following the US CB Consumer Confidence data released on July 28, 2026, which came in at 90.8, missing the forecast of 92.4 and signaling potential headwinds for the broader consumer sector.